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Dr Gerald Lawrie (Houston, Tex). This is a large series of pa-
tients, the biggest reported to date, and it also includes the
broader spectrum of severity of disease of any previous report.
It is also unique in that many of the patients had their PH diag-
nosed by RHC. Up to 40% of patients in previous studies have
been excluded because insufficient tricuspid regurgitation has
been present to allow them to assess pulmonary artery pressure
by echocardiography.
This study has confirmed the findings of smaller earlier studies
that an sPAP greater than 50 mm is a strong independent predictor
of early and late survival. This study also demonstrated that in all
categories of PH, regression of PH is incomplete after surgery,
reaching approximately 40 mm systolic after 2 years. Despite
the fact that surgery improves the prognosis at all levels of pulmo-
nary artery pressure, regression is incomplete because the PH seen
in severe MR arises not only from the MR itself but also from a se-
ries of complex changes in the left ventricle and LA morphology
and their systolic and diastolic function. The pulmonary artery
bed may develop increased vascular tone, and some degree of pul-
monary hypertensive vasculopathy may develop as seen in mitral
stenosis. Some of these changes, once present, may not regress de-
spite relief of the MR.
These findings and those of this study suggest it may be impor-
tant to pursue the issue of PH more aggressively and specifically
than we have done to date.
First, these data provide further strong support for surgery early
after the diagnosis of asymptomatic severe MR. Intraoperatively,
improvement of LA function by atrial fibrillation ablation and vol-
ume reduction surgery could benefit, and I think we need to look
more carefully at the influence of surgery on left ventricular dia-
stolic function to try to refine our techniques to preserve left ven-
tricular and LA function.
In patients presentingwith PH in the 60 to 80mm range, we have
formanyyears involved our pulmonologists early preoperatively to
evaluate andmanage the PH and exclude other contributory causes.
It is noteworthy that 21% of the patients in this study with pulmo-
nary artery pressures greater than 60 had significant chronic ob-
structive pulmonary disease. It may be that this pulmonary
evaluation should be extended to include RHC in all cases with
drug evaluation for pulmonary artery vascular responsiveness.
Because incomplete regression of the pulmonary artery pres-
sure was still present 2 years after surgery, it also may be that these
patients should be followed long-term by a pulmonologist, some-
thing we have not done, and a cardiologist. Long-term pulmonary
artery drug therapy could be beneficial in some cases.
Thank you for this excellent presentation, which I think has
brought a neglected topic to our attention. I do have 2 questions
for the presenter.
What proportion of the patients with no tricuspid regurgitation
on echo had RHC showing significant PH? Do you think that all
patients undergoing mitral repair with no TR should have RHC
to assess their pulmonary artery pressure before they go to sur-
gery? The second question relates to the fact that you agree we
have a big problem here that we have neglected and that the ap-
proach to the care of these patients with persistent significant PH
should involve long-term follow-up with a pulmonologist with ac-
tive treatment to moderate their PH.The Journal of Thoracic and CarDr Ghoreishi. To respond to your first question, we could
not assess the sPAP based on echocardiography because of
an absent tricuspid regurgitation jet velocity in 15% of pa-
tients. Among these patients, sPAPs were greater than 40 in
37% as measured on RHC. In 373 patients who were studied
with both echocardiography and RHC, we found a reasonably
good correlation between the results of echo and RHC, al-
though there was significant variability. We expect some dis-
crepancies between measurement of sPAP with RHC and
echocardiography. Pulmonary artery pressures are dynamic,
and the echocardiography and RHC were performed at differ-
ent times.
We believe that the current recommendation to operate after the
sPAP exceeds 50 mm Hg is associated with compromised early
and late outcomes, and therefore we are recommending moving
that threshold back to 40 mm Hg.
We advocate RHC for patients with asymptomatic severe MR
who are managed nonsurgically to make sure that PH (sPAP 
40 mm Hg) is not present.
To respond to your second question, we currently do not have
any therapeutic protocols directed at residual PH. We found that
during follow-up, sPAP in patients with preoperative PH (sPAP
 40 mm Hg) never decreased to normal after surgery. We agree
with you that these patients may benefit from long-term pharmaco-
logic treatment after surgery and follow-up with a multidisciplin-
ary team including a pulmonologist, but currently we don’t have
a protocol for these patients.
Dr Thierry Mesana (Ottawa, Ontario, Canada). Congratula-
tions for this large and interesting study. I noticed you had 12%
mortality in those with high severe PH, and you basically had al-
most no mortality in the patients with leaflet prolapse. Does this
mean that most of your mortality was in the patients without or-
ganic disease, such as ischemic patients?
Dr Ghoreishi. The number of patients with severe PH was low
in patients with degenerative MR. In the entire group, more than
30% of patients had moderate or severe PH, and patients with
higher degrees of preoperative PH were more likely to have func-
tional and rheumatic MV disease.
Dr Mesana. Patients with severe PH may not have the same
level of PH at the time of operation. So when did you take
your measurements to consider the patient as having severe
PH? You can have a patient with a pulmonary systolic pressure
of 60 before surgery, going down to 40 during anesthesia, and
it is the same patient. So when did you qualify the patient with
severe PH?
Dr Ghoreishi. Determination of the presence and degree of PH
in this study was based completely on preoperative evaluation, not
intraoperative assessment.
Dr Chitwood. No Swan–Ganz?
Dr Ghoreishi. No.
Dr Mesana. No Swan–Ganz in the operating room?
Dr Ghoreishi. We routinely measure the pulmonary artery
pressure intraoperatively, but the results in this study are based
on catheterization-derived SPAP performed preoperatively.
Dr Chaw-Chi Chiu (Kaohsiung, Taiwan). You didn’t mention
the diastolic pulmonary artery pressure in your presentation. As
we know, elevated diastolic pulmonary artery pressure is impor-
tant to evaluate the reversibility of PH after the operation.diovascular Surgery c Volume 142, Number 6 1451
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and the left ventricular end-diastolic pressures are more than 10
mm Hg, it would mean irreversibility of the PH even after the op-
eration. I would like to suggest measuring the diastolic pulmo-
nary pressure before operation to evaluate if the PH will
decrease after operation.
Dr Dan Lindblom (Stockholm, Sweden). I am currently work-
ing in Africa on different humanitarian projects, mainly in Sudan
on a big project where we are doing a lot of valve surgery. Last
year, we performed more than 600 MV procedures, obviously
mainly for mitral stenosis in young patients. More than half of
our patients came to surgery with a pulmonary pressure more1452 The Journal of Thoracic and Cardiovascular Surthan 60 mm Hg, and supersystemic pulmonary pressures were
not uncommon.
In your experience, do you have any cutoff line where you
would refuse the patient for surgery because of extreme PH?
What precautions would you take if you have a patient with very
high pulmonary pressures?
Dr Ghoreishi. Twenty-five patients in this study had an sPAP
greater than 80 mm Hg, and operative mortality was significantly
higher (17%) among those patients. However, we do not have any
absolute cutoff point to refuse surgery because a good number of
patients with significant PH can expect some symptomatic benefit
from operation.gery c December 2011
